.Pharmacolibrary.Drugs.ATC.N.N05AG02 .Pharmacolibrary.Drugs.ATC.N.N05AG02| name: | Pimozide |
| ATC code: | N05AG02 | route: | oral |
| n-compartments | 1 |
Pimozide is a typical antipsychotic drug of the diphenylbutylpiperidine class, primarily used in the treatment of chronic psychotic disorders such as Tourette's syndrome and schizophrenia. Although approved for use, it is less commonly prescribed today due to the risk of severe side effects, such as QT prolongation and arrhythmias.
Pharmacokinetic parameters reported in healthy adult volunteers following oral administration.
Sallee, FR, et al., & Perel, JM (1987). Pharmacokinetics of pimozide in adults and children with Tourette's syndrome. Journal of clinical pharmacology 27(10) 776–781. DOI:10.1002/j.1552-4604.1987.tb02995.x PUBMED:https://pubmed.ncbi.nlm.nih.gov/3480904
Yonkers, KA, et al., & Blumenthal, S (1992). Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. The American journal of psychiatry 149(5) 587–595. DOI:10.1176/ajp.149.5.587 PUBMED:https://pubmed.ncbi.nlm.nih.gov/1575248
Migdalof, BH, et al., & Janssen, PA (1979). Penfluridol: a neuroleptic drug designed for long duration of action. Drug metabolism reviews 9(2) 281–299. DOI:10.3109/03602537908993895 PUBMED:https://pubmed.ncbi.nlm.nih.gov/385274